4 JULY 2013

NEW ZEALAND GAZETTE, No. 85

Schedule 1

Prescription Medicines

• 5-aminolevulinic acid
• Abiraterone acetate
• Afamelanotide
• Aflibercept
• Amorolfine; except when specified elsewhere in this notice; except in preparations for the treatment of tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board
• Apixaban
• Asenapine
• Axitinib
• Azelastine; except when specified elsewhere in this notice
• Belatacept
• Belimumab
• Boceprevir
• Cabazitaxel
• Canagliflozin
• Catumaxomab
• Ceftaroline fosamil
• Cholera vaccine; except in the form of an oral liquid containing Vibrio cholerae when sold in a pharmacy by a registered pharmacist
• Cobicistat
• Cyclizine; except when specified elsewhere in this notice
• Clotrimazole; except in medicines for vaginal or external use
• Dapagliflozin propanediol
• Degarelix
• Denosumab
• Diclofenac; in preparations for the treatment of solar keratosis; except when specified elsewhere in this notice; except in preparations for external use other than for the treatment of solar keratosis
• Dronedarone
• Econazole; except in medicines for vaginal or dermal use
• Eculizumab
• Elvitegravir
• Eribulin mesylate
• Febuxostat
• Ferric carboxymaltose
• Fingolimod
• Follistatin
• Guaiphenesin; for oral use in medicines containing more than 2% or 200 milligrams per dose form except when specified elsewhere in this notice; except for oral use in modified release form with a maximum recommended daily dose of not more than 2.4 grams when sold in the manufacturer’s original pack containing not more than 10 days’ supply
• Icatibant
• Indacaterol
• Influenza vaccine; except when administered to a person 18 years of age or over by a registered pharmacist who has successfully completed a vaccinator training course approved by the Ministry of Health and who is complying with the immunisation standards of the Ministry of Health
• Ingenol mebutate
• Ipilimumab
• Isoconazole; except in medicines for vaginal or dermal use
• Linagliptin
• Lixisenatide
• Lovastatin; except when present as an unmodified, naturally occurring substance in a food that has not been subject to a manufacturing process other than heating, freezing, drying, preserving, bottling, canning, or packaging in retort pouches
• Mercurochrome; except when specified elsewhere in this notice
• Miconazole; except when specified elsewhere in this notice; except in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board
• Nitisinone
• Nomegestrol
• Nystatin; except when specified elsewhere in this notice; except in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board
• Ofatumumab
• Omeprazole; except when specified elsewhere in this notice
• Oseltamivir; except when specified elsewhere in this notice
• Pantoprazole; except when specified elsewhere in this notice
• Pertuzumab
• Pitavastatin
• Plerixafor
• Prucalopride
• Pseudoephedrine
• Ranitidine; except when specified elsewhere in this notice; except in medicines containing 150 milligrams or less per dose unit when sold in the manufacturer’s original pack containing not more than 7 days’ supply
• Remestemcel-L
• Rifaximin
• Rilpivirine
• Rupatadine
• Sapropterin
• Tafluprost
• Taliglucerase alfa
• Telaprevir
• Terbinafine; except in medicines for dermal use
• Teriflunomide
• Ticagrelor
• Tioconazole; except in medicines for vaginal or dermal use
• Tolvaptan
• Trastuzumab emtansine
• Trimethoprim; except in medicines for oral use containing 300 milligrams or less per dose unit when sold in a pack of 3 solid dosage units to a woman aged 16–65 years for the treatment of an uncomplicated urinary tract infection by a registered pharmacist who has successfully completed the New Zealand College of Pharmacists’ training in the treatment of urinary tract infections
• Tuberculin
• Velaglucerase alfa
• Vemurafenib
• Vilanterol
• Vorinostat

Schedule 2

Restricted Medicines

• Adrenaline; in medicines containing 1% or less except in medicines for injection containing 0.02% or less
• Brompheniramine; for oral use in medicines for adults or children over 2 years of age other than in medicines used